Company Filing History:
Years Active: 1986
Title: Ulf Tunn: Innovator in Prostate Health Solutions
Introduction
Ulf Tunn is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of prostatic hyperplasia. With a total of 2 patents to his name, Tunn's work focuses on innovative pharmaceutical solutions.
Latest Patents
Tunn's latest patents include groundbreaking methods for combining an aromatase-inhibitor and an antiandrogen. One patent describes a combination of these substances in a weight ratio of 20:1 to 1:1, which is useful in the prophylaxis and treatment of prostatic hyperplasia. The aromatase-inhibitor mentioned is testolactone, while the antiandrogen is cyproterone acetate. Another patent highlights the use of aromatase-inhibitors for the prophylaxis and treatment of benign prostatic hyperplasia, emphasizing the effectiveness of testolactone in pharmaceutical preparations.
Career Highlights
Ulf Tunn is associated with Schering Aktiengesellschaft, a company known for its advancements in pharmaceuticals. His work has contributed to the development of effective treatments for prostate health, showcasing his commitment to improving patient outcomes.
Collaborations
Tunn has collaborated with notable colleagues such as Hans-Udo Schweikert and Theodor Senge. These partnerships have likely enhanced the innovation and effectiveness of his research and patents.
Conclusion
Ulf Tunn's contributions to the field of medicine, particularly in the treatment of prostatic hyperplasia, demonstrate his innovative spirit and dedication to improving health solutions. His patents reflect a significant advancement in pharmaceutical therapies, marking him as a key figure in this area of research.